Kansas City, Kan- Ashley Graver, a Kansas woman, shared her journey with melanoma, the most aggressive form of skin cancer. Initially diagnosed in 2008, she underwent a wide excision and immunotherapy, achieving "no evidence of disease" (NED).

However, the cancer recurred twice, once in 2018 and again in 2024. Dr. Larry Corum, her oncologist, emphasized the effectiveness of immunotherapy in treating melanoma, noting significant improvements in survival rates.

Ashley's story highlights the importance of sun protection and the evolving treatment options in cancer care. Her advocacy work includes raising awareness about melanoma prevention.

Ashley Graver, patient

•  Ashley recounts the shock of discovering the cancer had returned 10 years later in her armpit.
• She shares her hope and the term "NED" (No Evidence of Disease) after successful treatment.
• Ashley talks about her advocacy work with the local nonprofit Outpacing Melanoma and her participation in their events.

Dr. Larry Corum, Medical Oncologist, The University of Kansas Cancer Center

•  Dr. Corum explains the staging of Ashley's recurrence and the hope for surgical removal and immunotherapy.
• He discusses the unique biology of melanoma and the effectiveness of immunotherapy in stimulating the immune system.
• Dr. Corum explains the differences in treatment between Ashley's first and third recurrences, including the use of combination immunotherapy.

Dr. Gary Doolittle, Melanoma Specialist, The University of Kansas Cancer Center, Director of Masonic Cancer Alliance, The University of Kansas Cancer Center

• Dr. Gary Doolittle explains the unpredictable nature of melanoma and the importance of early detection and treatment.
• He highlights the revolutionary impact of immunotherapy on melanoma treatment and cancer care in general.